Navigation Links
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Date:8/3/2009

reated patients (P < 0.0001). During the double-blind phase of the study, fewer patients treated with INVEGA(R) SUSTENNA(TM) experienced a relapse (10% [n=15/156]) compared with those in the placebo group (34% [n=53/156]).

Because maintenance of efficacy was demonstrated, the trial was ended early. Patients on INVEGA(R) SUSTENNA(TM) experienced a significant delay in time to relapse compared to placebo. Patients on placebo had a 3.6 fold higher incidence of experiencing relapse versus INVEGA(R) SUSTENNA(TM). As such, INVEGA(R) SUSTENNA(TM) has the potential to be of tremendous benefit for physicians, caregivers and patients.

In clinical trials, the most common adverse events (incidence greater than or equal to 5% and occurring at least twice as often as placebo) were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder.

"INVEGA(R) SUSTENNA(TM) provides healthcare professionals the opportunity to rethink their overall approach to how they treat schizophrenia by using long-acting therapies," said Husseini Manji, M.D., F.R.C.P.C., Global Therapeutic Area Head, Neuroscience, Johnson & Johnson Pharmaceutical Research & Development. "The approval of INVEGA(R) SUSTENNA(TM) demonstrates our commitment to providing valuable novel therapies for schizophrenia. INVEGA(R) SUSTENNA(TM) has a demonstrated safety profile that can help healthcare professionals address the issue of medication adherence and can also help many patients delay the time to relapse."

Visit http://www.INVEGASUSTENNA.com for full prescribing information.

IMPORTANT SAFETY INFORMATION FOR INVEGA((R)) SUSTENNA(TM)

INVEGA((R)) SUSTENNA(TM) is not approved for the treatment of dementia-related psychosis in elderly patients. Elderly
'/>"/>

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
2. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
3. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
4. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
5. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
6. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
7. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
10. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
11. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will ... on Wednesday, May 6, 2015, following the close of the ... conference call and live webcast on the same day at ... discuss the financial results.  To access the ... the "Investors" link.  Please log onto the webcast prior to ...
(Date:4/16/2015)... Kenneth C. Frazier , chairman and chief executive officer ... the Board of the Pharmaceutical Research and Manufacturers of America ... John J. Castellani announced that he will be retiring ... to PhRMA Board Frazier formerly held the position ... and CEO of Pfizer, Inc. Also elected were George ...
(Date:4/16/2015)... YORK , April 16, 2015 An ... additional way to generate trimers from the major HIV ... could benefit future clinical development of HIV vaccine candidates ... the critical target on the surface of HIV for ... an important platform for AIDS vaccine discovery, says ...
Breaking Medicine Technology:Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5New Method Holds Promise for HIV Vaccine Development 2
... Corporation (Nasdaq: GNBT, www.generex.com ), the leader in ... of the mouth, today announced that it has been ... Canadian Intellectual Property Office granted Canadian Patent No. 2,401,942, ... Application". This new patent increases the number ...
... International Corporation (Nasdaq: PRXL ) announced today it ... Conference in New York.  James Winschel, Senior Vice President and ... at 11:45 a.m. ET on Tuesday, October 5, 2010. ... through the "Investors" section of PAREXEL,s website at ...
Cached Medicine Technology:Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 2Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 3PAREXEL International to Present at William Blair Emerging Growth Stock Conference 2
(Date:4/18/2015)... 2015 Aureus Medical Group (web: ... physical therapy jobs, has announced that it will ... Physical Therapy Association Annual Conference to be held ... Greenville, SC. , The SCAPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:4/18/2015)... 2015 French physician and gastronome Anthelme ... when he uttered, “Tell me what you eat, and ... to cope with stress or sadness has often been ... indicates otherwise. Data collected from their Emotional Eating ... emotional eating, but for different reasons. , Collecting data ...
(Date:4/17/2015)... NY (PRWEB) April 18, 2015 Rosetta ... their facility, rounding out their list of diagnostic imaging ... center for patients on the Upper East Side of ... running at full capacity. The addition of PET-CT, combined ... their physicians the ability to work with patients through ...
(Date:4/17/2015)... Alcohol and Violence , The National ... drinking and driving has been the focus of much ... the link between alcohol and crime received less public ... and sexual assault, and their relationship to alcohol have ... million adults in America were drinking alcohol at the ...
(Date:4/17/2015)... Springs, Texas (PRWEB) April 17, 2015 From ... four years ago, the Texas non-profit organization has empowered young ... of its effort to bring fresh water and the ... partnered with Liberty University. Between March 17 and 27, students, ... will provide 7,000 Liberians with fresh water and the Good ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2
... - A Purdue University researcher is working on a new ... accurately reflects real-world situations. , "The traditional way to assess ... them in a quiet room and ask them to repeat ... Iler Kirk, a professor of speech, language and hearing sciences. ...
... prescriptions a factor in trend, expert says , , THURSDAY, Sept. ... from 2003 to 2004, the largest annual increase in 15 ... new government report shows. , "Our news today is sobering ... of the National Center for Injury Prevention and Control ...
... Sept. 6 In response to,reports about the potential ... Richman today reassured employees that the,civil section of the ... intention of closing the civil section of Warren,State Hospital ... care in,which residents and counties have come to depend," ...
... vision to provide health benefits offerings to Hispanic consumers ... and business ... Inc., a nationwide health,benefits provider that offers uninsured or partially ... the,formation of its latest partnership with International Gateway Insurance,Brokers, Inc. ...
... HOUSTON - Congestive heart failure rarely occurs among leukemia ... Texas M. D. Anderson Cancer Center found after an ... patients who enrolled in clinical trials for the drug. ... symptoms that could have been caused by heart failure. ...
... will participate in a nationwide study to pinpoint the ... infection. , The objective of this trial is ... people who have MRSA, said David Karras, professor and ... Medicine and Hospital, who will lead the research efforts ...
Cached Medicine News:Health News:Researcher developing new method for hearing loss assessment 2Health News:Teen Suicides Up Sharply for First Time in Years 2Health News:Teen Suicides Up Sharply for First Time in Years 3Health News:PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors 2Health News:International Gateway Insurance Brokers Partners With MEDILINQ 2Health News:International Gateway Insurance Brokers Partners With MEDILINQ 3Health News:Study finds heart failure is rare among leukemia patients on imatinib 2Health News:Study finds heart failure is rare among leukemia patients on imatinib 3Health News:Temple Emergency Medicine receives $1.8M to find best MRSA treatment 2Health News:Temple Emergency Medicine receives $1.8M to find best MRSA treatment 3
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... The Vivid 3 system is designed ... of cardiovascular performance, and offer an even ... pediatrics and the OR. From color flow ... connectivity, the new Vivid 3 offers a ...
... 4 system is an easy-to-use, high-performance ultrasound ... your clinical practice. In effect, GE has ... a value-based combination of proven technology and ... paid heed to features praised by Vivid ...
... remote monitoring from Medtronic is changing the ... care. Using their Medtronic CareLink Monitor and ... send device information from their home or ... site, clinicians have the ability to review ...
Medicine Products: